WO2002065092A2 - Dispositifs et procedes destines a des tests patch clamp a haut debit - Google Patents
Dispositifs et procedes destines a des tests patch clamp a haut debit Download PDFInfo
- Publication number
- WO2002065092A2 WO2002065092A2 PCT/US2002/003700 US0203700W WO02065092A2 WO 2002065092 A2 WO2002065092 A2 WO 2002065092A2 US 0203700 W US0203700 W US 0203700W WO 02065092 A2 WO02065092 A2 WO 02065092A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- opening
- well
- cell
- wells
- cells
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 108
- 238000003556 assay Methods 0.000 title description 7
- 210000004027 cell Anatomy 0.000 claims abstract description 199
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 66
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 25
- 238000010438 heat treatment Methods 0.000 claims abstract description 24
- 239000012530 fluid Substances 0.000 claims abstract description 12
- 238000004891 communication Methods 0.000 claims abstract description 8
- 239000011521 glass Substances 0.000 claims description 74
- 102000004310 Ion Channels Human genes 0.000 claims description 52
- 239000000243 solution Substances 0.000 claims description 45
- 238000005259 measurement Methods 0.000 claims description 43
- 241000238366 Cephalopoda Species 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 239000012528 membrane Substances 0.000 claims description 17
- 239000003292 glue Substances 0.000 claims description 15
- 230000004048 modification Effects 0.000 claims description 13
- 238000012986 modification Methods 0.000 claims description 13
- 239000004033 plastic Substances 0.000 claims description 13
- 229920003023 plastic Polymers 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000000151 deposition Methods 0.000 claims description 8
- 239000008151 electrolyte solution Substances 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 7
- 239000012620 biological material Substances 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 238000011156 evaluation Methods 0.000 claims description 4
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 2
- 238000007385 chemical modification Methods 0.000 claims 1
- 238000004093 laser heating Methods 0.000 claims 1
- 108090000862 Ion Channels Proteins 0.000 description 46
- 150000002500 ions Chemical class 0.000 description 22
- 150000002632 lipids Chemical class 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 19
- 239000003814 drug Substances 0.000 description 18
- 229940079593 drug Drugs 0.000 description 16
- 229910052799 carbon Inorganic materials 0.000 description 14
- 108091006146 Channels Proteins 0.000 description 13
- 238000012216 screening Methods 0.000 description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 12
- 239000012039 electrophile Substances 0.000 description 11
- 125000000524 functional group Chemical group 0.000 description 9
- 239000012038 nucleophile Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000005553 drilling Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 229940000406 drug candidate Drugs 0.000 description 7
- 230000003834 intracellular effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000013537 high throughput screening Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000000232 Lipid Bilayer Substances 0.000 description 5
- 239000005388 borosilicate glass Substances 0.000 description 5
- -1 buffers) Chemical class 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 230000011664 signaling Effects 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical group [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 3
- 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001412 amines Chemical group 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 150000002118 epoxides Chemical class 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000012402 patch clamp technique Methods 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 150000001502 aryl halides Chemical class 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 150000001541 aziridines Chemical class 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000037765 diseases and disorders Diseases 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 238000003372 electrophysiological method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000002780 ion channel assay Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 230000004576 lipid-binding Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 229960000988 nystatin Drugs 0.000 description 2
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-O oxonium Chemical compound [OH3+] XLYOFNOQVPJJNP-UHFFFAOYSA-O 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 239000005368 silicate glass Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 101710099641 Proton-gated ion channel Proteins 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000000823 artificial membrane Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007819 coupling partner Substances 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000005361 soda-lime glass Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000007944 thiolates Chemical class 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48728—Investigating individual cells, e.g. by patch clamp, voltage clamp
Definitions
- This invention relates generally to electrophysiological evaluations of biological materials. More specifically, the invention relates to devices and techniques for measuring and evaluating electrophysiological properties associated with ion channels in cell membranes. The invention is further related to techniques for creating a gigaseal between a cell membrane and the surface of a patch clamp probe to facilitate high throughput measurements of electrophysiological properties. BACKGROUND
- Ion channels control the flow of ions in and out of cells.
- ion channels are imbedded in lipid bilayers that comprise cell membranes.
- the movement of ions through cell membranes via ion channels creates ionic currents that give rise to weak but measurable electrical currents.
- the patch clamp method enables the measurement of ionic currents flowing through ion channels.
- a patch clamp technique is described in for example, PCT publication serial nos. WO 96/13721 and WO 99/66329, which are incorporated herein by reference in their entirety.
- the patch clamp method uses the ability of a cellular membrane to form a tight seal between the membrane and the recording probe, thus minimizing background ionic currents from "leakage" between the cell membrane and the recording probe.
- a micropipette tip engages a membrane and forms a seal.
- Such a seal known in the art as a “gigaseal,” has a high resistance that facilitates precise measurement of weak ionic currents flowing through ion channels in the cell membrane.
- ion channels have "gates" that open in response to external stimuli.
- External stimuli may include electrical potentials, mechanical or tactile stimuli, and signaling molecules.
- Signaling molecules are essentially chemical stimuli, and classes of ion channel gates, which respond to chemical stimuli, are known in the art as ligand-gated ion channels.
- Ligand-gated ion channels respond to both naturally occurring signaling molecules and to synthetic molecular signals such as drugs. Examples of signaling molecules for ligand-gated channels include acetylcholine and glycine (neurotransmitters), cyclic AMP, inositol 1,4,5 triphosphate (IP ), and ATP (intracellular).
- the patch clamp method is a low throughput assay for drug candidates.
- a major bottleneck concerns the formation of a gigaseal between the membrane and the tip of a pipette.
- Current technology for forming a gigaseal is tedious and requires special training and equipment.
- An experienced electrophysiologist now can screen only about 5 to 20 compounds a day using existing patch clamp techniques, whereas modern drug screening (e.g., using non-patch clamp techniques, and characterized by 96-well plates, robotic handling, and automated data processing) can screen thousands or tens of thousands (or greater) of compounds per day depending on the particular assay.
- the present invention provides a variety of devices and methods for measuring, evaluating, recording, and analyzing electrophysiological properties of cells and biological membranes.
- the device and methods of the present invention utilize a gigaseal between a cell or biological membrane and an opening.
- devices and methods for enabling automated ion channel assays and the parallel processing and screening of many drug candidates and many cells at once, utilizing a gigaseal between a cell and an opening in a glass sheet or plate, are provided.
- An embodiment of the present invention comprises a device for measuring electrophysiological properties of a cell membrane of an individual cell, the device comprising: a plate provided with at least one opening, wherein the opening is bounded by a surface and wherein the surface is modified to facilitate formation of a gigaseal; a chamber adjacent to the plate, wherein the chamber is in fluid communication with at least one opening and is adapted to hold a solution; a first electrode located in the chamber; a second electrode located adjacent to the plate; and wherein electrophysiological properties of a cell membrane of an individual cell is measured using the device.
- Another embodiment of the present invention comprises a device for measuring electrophysiological properties of a cell membrane of an individual cell, the device comprising: a plate provided with at least one well, wherein the well is provided with an opening modified to receive an individual cell, wherein the opening is created using a laser and the opening is modified via heating; a chamber adjacent to the plate, wherein the chamber is in fluid communication with the opening and is adapted to hold an electrically conductive solution; a first electrode located in the chamber; a second electrode located in the well; and an amplifier in electrical contact with the first and second electrodes, wherein electrophysiological properties of a cell membrane of the individual cell are recorded by measuring a current through the first and second electrode.
- Another embodiment of the present invention comprises a removable disk comprising an opening wherein the disk serves as part of a well for use in measuring electrophysiological properties of a cell membrane.
- Another embodiment of the present invention comprises a method for evaluating currents flowing through ion channels of a cell membrane, the method comprising: providing at least one well comprising an opening having a modified surface to receive a cell comprising a cell membrane; depositing the cell into the opening wherein the modified surface creates a gigaseal between the cell and the well; and recording voltage and/or current measurements to evaluate the ion channel of the cell membrane.
- Another embodiment of the present invention comprises a method for creating a gigaseal, the method comprising: providing at least one well comprising an opening; depositing a solution comprising a plurality of cells into the well; providing a positive pressure to the opening; and providing a negative pressure to the opening, sucking one of the plurality of cells to the opening creating a gigaseal between the cell and the opening.
- a technical advantage of one embodiment of the present invention is that a device that facilitates the formation of a gigaseal is provided. Such device provides enhanced signal detection and amplification for the measurement of ionic current. Further, such device provides features that enhance high throughput screening of drug candidates. Additionally, methods of fabricating the device and components of the disclosed invention are disclosed.
- a technical advantage of an embodiment of the present invention is that novel ways to create an electrically resistive gigaseal between a cell membrane and the recording probe to facilitate the measurement of ionic currents flowing through a cell membrane are provided. Further, methods of chemically and physically modifying the surface of the probe, which engages the cell membrane, are disclosed. Surface modifications that facilitate the formation of a gigaseal include, but are not limited to: (1) heat treatment for specific time periods, (2) the covalent binding of lipid molecules, and (3) the application of a glue-like substance. In one embodiment, such modifications are used with existing patch clamp type experiments, and may also be used to facilitate high throughput screening procedures.
- a technical advantage of an embodiment of the present invention is that novel ways to screen ion channels in a high throughput fashion are provided. Such screening techniques may utilize gigaseals.
- Another technical advantage of one embodiment of the present invention is that the number of whole cell patches that may be assayed is increased from the current 5 to 20 per eight hour day to 200 to 2000 (or greater) per day.
- FIG. 1 illustrates a device for measuring electrophysiological properties according to an embodiment of the invention
- Fig. 2 is front perspective view of a high throughput screening device according to an embodiment of the invention
- Fig. 3 is a cross sectional schematic diagram of the screening apparatus of Fig. 2;
- Fig. 4 is a front perspective view of a multi-well plate that is used in connection with the screening device of Fig. 3;
- Fig. 5 illustrates another embodiment of an electrophysiological measuring device according to an embodiment of the invention
- Fig. 6 is a more detailed view of an opening in one of the wells of the screening device of Fig. 5;
- Fig. 7 illustrates the screening device of Fig. 6 after a cell has been drawn into the opening according to one embodiment of the invention;
- Fig. 8 illustrates the common electrode that is translated to sever a portion of the cell that is sealed to the through opening according to one embodiment of the invention
- Fig. 9 illustrates the common electrode when moved back to its home position so that measurements of electrophysiological properties may be taken according to one embodiment of the invention
- Fig. 10 is a top perspective view of one embodiment of a multi- well plate that may be used in a high throughput screening device according to an embodiment of the invention
- Fig. 11 is a top view of the multi -well plate of Fig. 10;
- Fig. 11 A is a more detailed view of a well of the multi-well plate of the Fig. 11 taken along detail A;
- Fig. 1 IB is a more detailed view of the well of Fig. 11 A taken along detail B;
- Fig. 1 IC is a cross sectional side view of one of the wells of the multi-well plate of
- Fig. 1 ID is a more detailed view of a through opening in the well of Fig. 1 IC taken along detail D;
- Fig. 1 IE is a more detailed view of the through opening of Fig. 1 ID taken along detail
- Fig. 1 IF is another embodiment of a through opening in the plate which is substantially less conical in shape than that in Fig. 1 IE;
- Fig. 12 shows a two stage opening comprising a counter bore and a through hole;
- Fig. 13 A is an oblique view of another embodiment of a multi-well plate according to an embodiment of the present invention.
- Fig. 13B is an exploded view of a multi-well plate comprising a glass plate and a plastic sheet also showing a test vacuum fixture according to an embodiment of the present invention
- Fig. 13C shows an oblique close-up view of one well of a multi-well plate according to an embodiment of the present invention
- Fig. 13D shows another oblique close-up view of one well according to an embodiment of the present invention
- Fig. 14 illustrates a patch clamp micro chamber according to one embodiment of the invention
- Fig. 15 illustrates a patch clamp micro chamber with a glass disk according to one embodiment of the invention
- Fig. 16 illustrates the covalent attachment of a lipid to a plate surface according to one embodiment of the invention
- Fig. 17 illustrates the binding of lipid molecules near the opening in a patch clamp device according to one embodiment of the invention
- Fig. 18A illustrates a gigaseal formation according to one embodiment of the invention
- Fig. 18B illustrates a gigaseal formation according to another embodiment of the invention.
- Fig. 19A illustrates a patch clamp device with a SQUID detector according to an embodiment of the invention.
- Fig. 19B illustrates a patch clamp device with a SQUID detector according to another embodiment of the invention. DESCRIPTION OF THE SPECIFIC EMBODIMENTS
- biological membrane used herein is a cell membrane such as found in a whole cell and also includes artificial membranes such as lipid bilayers and other synthetic polymer membranes.
- electrophysiological properties is a measured electrophysicological property of a cell, cell membrane, or other biological membrane. These properties are measured using ionic current, voltage, or the magnetic field associated with an ion channel located in a cell membrane. Such measurements may be made in the presence (or absence) of indigenous factors like signaling molecules. Such measurements may also occur in the presence (or absence) of exogenous factors like candidate drug molecules or test compounds under screening conditions. Measurements of electrophysiological properties may also include the measurement of potentials across cell membranes or rates of ion migration through ion channels in the presence of indigenous or exogenous factors. The term electrophysiological property may also comprise the distinction of types of ions that flow through ion channels located in biological membranes.
- An "electrically conductive solution” is a solution comprising ions or electrolytes.
- Ions are charged atoms or molecules that bear a positive or negative charge such as cations and anions.
- cations include, but are not limited to: sodium (Na + ), potassium (K + ), lithium (Li + ) and other monovalent cations, calcium (Ca 2+ ), magnesium (Mg 2+ ) and other divalent cations.
- anions include, but are not limited to, chloride (Cl ⁇ ), iodide (I " ), and other halides.
- 'Ton channels are transmembrane proteins or assemblies of proteins that are imbedded in lipid bilayers that comprise cell membranes. Ion channels control the flow of ions in and out of cells.
- Ion channels may show specificity, e.g., they allow only specific ions to pass through cell membranes. Moreover, various diseases and disorders are closely associated with particular ions and their corresponding channels, for example, K-channels, or Na-channels. The movement of ions through cell membranes via ion channels creates ionic currents that create weak but measurable electrical currents. For this reason, the same cell or cell membrane may display different electrophysiological properties in the presence or absence of different ions, e.g., electrophysiological measurements are sensitive to the type of ion(s) present, in addition to being sensitive to parameters such as presence and concentration of molecular signals. Further, a voltage may be applied to induce the opening of ion channels in a cell membrane.
- experimental variables are factors that are operator controlled, e.g. such factors as temperature, duration of experiment (including duration of a current measurement), method of signal detection, and applied voltage. These factors may be changed from experiment to experiment by the operator and such changes may affect the outcome of a particular experiment.
- Other experimental variables include the presence of, and concentrations of ions (including buffers), molecular signals, or drug candidates under screening conditions.
- Another experimental variable comprises the type and number of cells present in an experiment.
- Ionic current is the flow of ions through ion channels. Ionic currents may also refer to ion migration in electrolytic solutions. When current flows in an electrolytic solution, charge may be carried by the motion of both anions and cations.
- the solvent in electrolytic solutions is often water, however, non-aqueous electrolytic solutions are known to the skilled artisan, and are within the scope of the present invention.
- a "patch clamp micro chamber” is a device for measuring electrophysiological properties of biological membranes wherein a gigaseal is formed in a single integrated device. Additionally, in one embodiment, chip signal amplification and/or processing can also occur in this single integrated device.
- a “gigaseal” or a “high resistance seal” is a patch clamp seal having minimal background ionic current from "leakage” due to a poor seal. According to a preferred
- a gigaseal is a high resistance seal of greater than about one giga-ohm (1 G ⁇ ).
- a gigaseal is a high resistance seal of between about one
- gigaseal is a high resistance seal of about one giga-ohm (1 G ⁇ ) to about 50 giga-ohm (50
- a gigaseal is a high resistance seal of about one
- a gigaseal is a high
- a "proton” is a hydrogen atom stripped of its sole electron. In aqueous solution, protons are associated with water molecules and are properly termed “hydronium ions” or H 3 O + . Frequent confusion of the terms persists in the open literature, especially in discussions of pH. Unless a distinction is drawn, the words proton and hydronium ion are used interchangeably herein.
- a “therapeutic agent,” e.g., a drug or prodrug, is any compound or formulation thereof which is effective in helping to prevent or treat a disease or condition.
- Effective in helping to prevent or treat a disease or condition indicates that administration in a clinically appropriate manner results in a beneficial effect for at least a statistically significant fraction of patients, such as a improvement of symptoms, a cure, extension of life, improvement in quality of life, or other effect generally recognized as positive by medical doctors familiar with treating the particular type of disease or condition.
- Diseases associated with ion channels and ion channel function include the cardiovascular area, including hypertension and cardiac arrhythmias, pain (local anesthetic), diabetes, epilepsy, anxiety, and the like. Each of these diseases or family of diseases tends to be associated with particular ion channels.
- the invention provides devices and methods to facilitate high throughput experiments to identify and screen drug candidates for the treatment of ion-channel associated diseases.
- Fig. 1 illustrates a device for measuring electrophysiological properties according to an embodiment of the invention.
- This device utilizes a dielectric barrier 2 that is used to separate a pair of electrodes 3 and 4.
- the dielectric barrier may be of any configuration or shape, e.g. a plate, disk or sheet, and may be integrated into another structure, e.g. the bottom, side or top end of a well or a chamber.
- a primary function of dielectric 2 is to separate electrodes 3 and 4.
- Dielectric 2 includes an opening 5 for receiving a cell 6.
- a variety of methods may be used to shape and form the openings. For example, a small conical hole can be drilled into the bottom of each well using a laser drilling technique.
- the opening has a diameter in a range of about 1 ⁇ m to about 5 ⁇ m, preferably 2 ⁇ m.
- the dielectric includes multiple openings and multiple electrodes so that multiple cells may be evaluated in parallel in multiple wells (one cell at a time).
- Dielectric barriers may be constructed from a variety of different materials, for example, glass or plastic. Glass with good insulating electrical properties is useful for patch clamp measurements. Moreover, it is useful to prevent substances from being leached from the glass, like ions, which can alter channel behavior. Other important aspects of the glass are good cell adhesion properties, high electrical resistivity, low dielectric constant, compatibility with laser drilling techniques, uniform thickness, and good flatness.
- borosilicate glass is used in the present invention.
- Borosilicate glass is chemically durable, stable against deformations up to about 700° C, and has excellent optical properties. Thus, this glass is suitable for applications where a sheet of smooth and flat glass with minimal thickness is required.
- a type of borosilicate glass that can be used is Erie Scientific Company's D 263 glass, which information regarding can be found at: "http://www.eriesci.com products&services/CustomGlass/D263-tech.html.” which is incorporated by reference herein in its entirety.
- other silicate glass or other types of glass may also be used.
- sodalime glass can be used for the plate portion of a patch clamp micro chamber.
- microscope slide cover slips can be made from this glass (or borosilicate glass) using a process resulting in flat, uniform, smooth glass sheets.
- a silica substrate is used according to an additional embodiment of the invention.
- Silicon wafers which are commercially used in the semiconductor industry, have a native oxide layer from air oxidation. Such chips and surfaces offer the advantages of a high quality smooth silica surface that may be functionalized using methods similar to those for the silicate glasses.
- Other materials suitable for constructing patch clamp micro chamber components include, but are not limited to, polymer surfaces.
- the activation of polymer surfaces may be achieved using a UN/ozone or a plasma process, and involve the creation of new chemical functional groups at the polymer surface, generated through ion and electron bombardment. The process is effective for increasing the surface wettability and also the affinity of charged bipolar lipid membranes of the polymer substrate.
- FIG. 2 shows a front perspective view of such an electrophysiological measuring device 10 according to one embodiment of the invention.
- Device 10 is constructed of a housing 12 having a pair of inputs 14 and 16 into which multi- well plates (having an array of wells) may be inserted.
- multi-well plate that may be used according to an embodiment of the present invention is a multi-well plate having a plastic body with a solid glass bottom.
- An example of such a plate is model No. 7706-2375, commercially available from Whatman Polyfiltronics.
- One of the plates may include cells while the other plate holds solutions that are transferred to the plate with cells.
- Positioned above input 14 and 16 are a set of control buttons 18 for controlling operation of device 10.
- control buttons 18 may be employed to dispense cells into the wells of the multi-well plates, to apply a pressure differential, to create a voltage gradient, to display various measured electrophysiological parameters, and the like. Following evaluation, the multi-well plates may be ejected from housing 12 and discarded.
- Fig. 3 is a cross sectional diagram of device 10 according to one embodiment of the invention.
- Input 14 leads to a generally open interior 20 for holding a multi-well plate 22 having a plurality of wells 24 as in Fig. 4 (a similar interior is in communication with input 16).
- plate 22 When plate 22 is positioned within interior 20, it is held over a chamber 26 having a common electrode 28.
- chamber 26 is filled with an electrolyte solution so that electrical current may be provided through openings in each of wells 24 by energizing common electrode 28 as described herein.
- Common electrode 28 is coupled to a control unit 29 having the appropriate electronics to provide current to common electrode 28.
- a dispensing device is employed to dispense compounds into each well.
- a multi-well dispensing device 30 having a plurality of dispensing tips 32. Coupled to each of the dispensing tips 32 is a line 34 leading to a reservoir in control unit 29.
- a suspension of cells in solution may be supplied to each dispensing tip 32 which in turn provides the cells (hundreds to thousands of cells) in solution into wells 24 of plate 22.
- each dispensing tip 32 further includes a well electrode 36 that provides a return current path from common electrode 28.
- the electrodes are separate from the dispensing tips, may be incorporated into the sides of the wells, may be a thin film electrode on the sides or ends of the wells, or the like.
- Each of well electrodes 36 is coupled to the electronics within control unit 29 so that a voltage gradient may be produced across cell membranes of the cells deposited in each of the openings in wells 24.
- control unit 29 includes the appropriate electronics to measure and record voltage and current changes for each of the cell membranes.
- the device may also include the ability to drain a well or chamber and to maintain a positive pressure or small vacuum to facilitate the formation of a gigaseal.
- a pressure differential is provided between each well 22 and chamber 26.
- Chamber 26 may be pressurized with a slight positive pressure or a slight negative pressure while cells are dispensed into the well to aid in formation of a gigaseal as described below. This may be accomplished by providing positive pressure through each of the dispensing tips 32 or by applying a vacuum within chamber 26. Control unit 29 may control this vacuum.
- Control unit 29 further includes appropriate electronics to record and store the electrophysiological properties.
- Control unit 29 may include appropriate input and output ports to permit this data to be electronically transferred to another computer or other storage device for future use.
- control unit 29 may be employed to lower dispensing tips 32 into wells 24 after plate 22 has been inserted into input 14. Following lowering of dispensing tips 32, control unit 29 may then be employed to dispense the cells into solution into each of wells 24 as previously described. Once the operation is complete, control unit 29 can be employed to automatically eject plate 22 from input 14 so that it may be removed and discarded.
- Fig. 5 illustrates another embodiment of an electrophysiological measuring device according to an embodiment of the invention.
- Device 38 comprises a housing 40 having an interior for holding a multi -well plate 42 having a plurality of wells 44. For convenience of illustration, only three wells are shown. However, it will be appreciated that device 38 can be constructed to have a wide variety of well configurations. In one example, the wells are
- plate 42 need not be horizontal
- Electrode 48 is coupled to appropriate electronics to permit a voltage gradient to be applied across cell membranes as described herein.
- Disposed above plate 42 is a multi-well dispensing device 50 having a plurality of dispensing tips 52.
- Dispensing device 50 is configured so that dispensing tips 52 may be inserted into wells 44 after plate 42 is inserted into device 38.
- Dispensing tips 52 may include a seal 54 to provide a seal between dispensing tips 52 and wells 44 when a pressure differential is applied to wells 44 as described herein.
- Each dispensing tip 52 further includes a well electrode 56.
- a voltage gradient may be provided between common electrode 48 and well electrodes 56 when performing measurements of electrophysiological properties of cells or cell membranes. Electrodes 56 are further coupled to appropriate electronics so that voltage and current measurements may be taken and recorded as illustrated in Fig. 5.
- each well 44 includes a tapered through opening 58 to provide a path for electrical current between common electrode 48 and well electrodes 56.
- cells 60 may be dispensed into wells 44 using dispensing device 50.
- Cells 60 are dispensed in a solution that is electrically conductive.
- Chamber 46 may also be filled with an electrically conductive solution so that a voltage gradient may be applied across the cell membranes of the cells in each well 44.
- Figs. 6-9 sequentially illustrate a method of utilizing device 38 according to embodiments of the present invention.
- Fig. 6 shows a more detailed view of an embodiment illustrating an opening in one of the wells of the screening device of Fig. 5.
- Cells 60 in a solution are dispensed into each well 44 using dispensing device 38.
- Common electrode 48 includes a plurality of openings 62 to correspond with each through opening 58. Initially, common electrode 48 may be shifted so that openings 62 are offset from through opening 58. Thus, the solution in wells 44 will not migrate into chamber 46.
- electrode 48 is translated to align opening 62 with through opening 58. This causes the solution in wells 44 to flow into chamber 46.
- a pressure differential may be provided to draw one of the cells 60 to the end of through opening 58 as shown.
- a pressure differential may be provided by supplying positive pressure through dispensing tips 52 and/or by providing a vacuum within chamber 46.
- the amount of pressure may be varied depending on the type of seal to be created between cell 60 and the side of through opening 58.
- the side of through opening 58 may optionally include a glue-like substance to create a high resistance seal between cell 60 and the sidewall of through opening 58.
- a glue is illustrated by reference numeral 64 in the figures.
- a pressure differential may also be provided to provide a gigaseal between cell 60 and the sidewall of through opening 58.
- a potential difference may be provided by applying a voltage difference between the electrodes to determine if an appropriate seal has been created. If not, the wells without a gigaseal are excluded from consideration.
- electrode 48 may be translated to perforate a bottom portion of cell 60 that extends below through opening 58.
- the interior part of cell 60 may be placed at the same potential as common electrode 48 when electrode 48 is moved back to the home position and a voltage gradient is applied as illustrated in Fig. 9.
- the cell wall portion that is circumscribed by a high resistance or gigaseal is cut to yield a "penetrated patch.”
- This may be accomplished, for example, by use of a cutter that is disposed adjacent the plate.
- the cutter can sever or produce one or more openings in cells protruding below the ends of the wells.
- a common electrode may be configured to function as the cutter.
- the interior of the cell may be placed at the same electrical potential as one of the common electrodes.
- the bottom of the cell may be perforated using pressure or electrical pulses or by using a Nystatin or other opening forming solution comprising an antibiotic.
- device 38 may utilize large pressure pulses to destroy the bottom portion of cell 60 or may use a Nystatin solution to create holes in the bottom portion of cell 60.
- measurements of electrophysiological properties may be made by applying a voltage gradient and measuring the cu ⁇ ent flowing through the ion channels in the cell membrane.
- device 38 multiple cells or cell membranes may be evaluated in parallel in a high throughput manner. Once the measurements are made, plate 42 may be removed and discarded.
- Fig. 10 shows one embodiment of a multi-well plate 66 that may be used with any of the measuring devices of the invention.
- Plate 66 is constructed of a plate body 68 having a "top" end 70 and a “bottom” end 72. A plurality of wells are formed in the plate body, with each well being open at end 70. Further, and as shown in Fig. 11, each well 74 has a "bottom" end 76.
- Plate body may be constructed of plastic, with end 76 being constructed of glass. For example, a glass sheet may be bonded to the bottom of polystyrene 96 well plate.
- Figs. 10 shows one embodiment of a multi-well plate 66 that may be used with any of the measuring devices of the invention.
- Plate 66 is constructed of a plate body 68 having a "top" end 70 and a "bottom” end 72. A plurality of wells are formed in the plate body, with each well being open at end 70. Further, and as shown in Fig. 11, each well 74 has
- FIG. 11A-11F show more detail of an embodiment of a multi-well plate 66 that may be used with any of the measuring devices of the invention.
- Fig. 11 A shows a more detailed view of a well 74 of the multi-well plate of Fig. 11 as shown in detail A.
- Fig. 1 IB is a more detailed view of the well 74 of Fig. 11 A as shown in detail B.
- Fig. 1 IC is a cross sectional side view of one of the wells 74 of the multi -well plate of Fig. 11.
- Fig. 1 ID is a more detailed view of a through opening in the well of Fig. 11C as shown in detail D.
- Fig. HE is a more detailed view of the through opening of Fig. 11D as shown in detail E.
- a conical opening 78 is used according to embodiments of the present invention.
- a conical opening 78 is used according to embodiments of the present invention.
- each bottom end 76 is an opening 78 to receive
- the taper angle of opening 78 and size of through hole 80 may be varied to optimize the gigaseal according to cell type and average cell size, for example, the tapered angle can be from approximately 1° to 90°. In one embodiment of the invention, the cells have an average
- the cells have an average diameter of about 8 ⁇ m to 80 ⁇ m. In another embodiment, the cells have an average diameter
- One technique for forming through opening 78 is by using a laser drilling process or related technique.
- Laser drilling is the process of repeatedly pulsing focused laser energy at a material, vaporizing layer by layer until a through-hole is created. This process creates what is known as a "popped" or "percussion drilled” hole.
- a popped hole could be as small as 1 ⁇ m in
- an ultraviolet laser is used to create these holes, however, an infrared laser can also be used. Additionally, the laser drilling process can be automated to more ensure accurate and precise drilling of the holes.
- the opening 85 in the plate 90 is substantially less conical in shape, deviating by only a several degrees from a line drawn perpendicular to the surface.
- An opening 85 may be further characterized as having a "large” end 86 and a “small” end 87, each having different diameters 97 and 99, respectively. According to one embodiment of the
- opening 85 has a diameter of approximately 7 to 9 ⁇ m on larger side 86 and approximately 1-3 ⁇ m on the small side 87.
- Fig. 1 IF is approximately lOO ⁇ m.
- the larger end of conical-shaped opening engages the cell and the smaller end opens to the chamber as illustrated in Fig. 1.
- the large and small ends are reversed and such that the smaller end of the opening engages a cell.
- Fig. 12 shows another embodiment of the invention, wherein a hole is constructed in two stages with a counter bore and a through hole. A relatively large (with a diameter 102 of
- the counter bore (or blind hole) 100 is drilled using a
- the counter bore 100 is drilled without use
- a cell 120 is significantly smaller than the counter bore yet larger than the opening of the through hole and seats atop the through hole when forming a gigaseal.
- the counter bore 100 and the through hole 115 are drilled using a laser.
- the laser has a wavelength of 193 nm for the counter bore 100 and 248 nm the through hole 115.
- the laser has a wavelength between approximately 150 and 300 nm for both the counter bore 100 and the through hole 115.
- the wavelength that is used to drill the hole is determined by the type of glass (or other material) that is being used. Some glass does not absorb well at 248 nm, so a 193nm laser may be used.
- both the counter bore 100 and through hole 115 can be drilled using the same wavelength laser, such as a 248 nm laser. If using the same laser, different masks may be used to change the laser beam diameter.
- Fig. 13 A shows an oblique view of another embodiment of a multi-well plate, such as a composite 96-well plate, according to an embodiment of the invention.
- a glass plate or sheet 125 is provided with a plurality of openings. The openings may be made using any of the methods described herein.
- a layer of plastic 130 e.g. a silicone elastomer, which is also provided with an a ⁇ ay of larger holes, may be overlaid or adhered to the glass plate.
- the resulting glass/plastic composite comprises a multi-well plate according to an embodiment of the invention.
- Fig. 13B is an exploded view of a multi-well plate comprising a glass plate and a plastic sheet also showing a test vacuum fixture according to an embodiment of the present invention.
- Fig. 13B also shows the lower chamber which further comprises vacuum fixture 135.
- Fig. 13C shows an oblique close-up view of one well 121 of a multi-well plate according to an embodiment of the invention.
- the well 121 comprises a plastic layer 130 adhered to a glass plate or sheet 125, which is provided with an opening 140. Opening 140 can comprise a counter bore and a through hole.
- the sides of well 121 therefore comprise plastic 130 and the bottom of well 121 comprises glass plate or sheet 125.
- Fig. 13D shows another oblique close-up view of one well 121 according to an embodiment of the invention. This "hidden lines visible" drawing of well 121 more clearly shows through hole having top 145 and bottom 150 openings. Again, the sides of well 121 comprise plastic 130 and the bottom of well 121 comprises glass plate or sheet 125.
- Fig. 13C shows an oblique close-up view of one well 121 of a multi-well plate according to an embodiment of the invention.
- the well 121 comprises a plastic layer 130 adhered to a glass plate or sheet 125, which is
- the device comprises a well 200 for receiving a solution 205 containing cell(s) 210.
- a well further comprises an electrode 215 that comprises silver coated with silver chloride.
- the electrode appears to rest on plate 220, however, and as described herein, the electrode may be connected to the sidewall of well 225, or in another embodiment, may be part of a liquid dispensing system as shown in Fig. 3.
- the patch clamp micro chamber according to Fig. 14 further comprises chamber 230 that holds an electrically conductive buffer solution along with a second electrode 235.
- the bottom of the chamber has a window 240 for inspection of the opening 245.
- the opening 245 receives an individual cell 210, such that measurements are taken on the individual cell 210 as described herein. Such measurements may measure electrophysiological properties of the cell or cell membrane and are recorded using commercially available patch clamp recording electronics designed for pipette-based ion channel recordings, such as a system manufactured by Axon Instruments or HEKA Elektronik.
- a patch clamp micro chamber may further comprise a tube
- a vacuum source 255 is coupled to the micro chamber via a tube 250 to produce a vacuum within the chamber, for example -1 to -5 kPa or -1 to -2 kPa.
- the vacuum allows a cell to be sucked to the opening 245, assisting in the formation of the gigaseal.
- a positive pressure is applied through the same tube.
- Such pressure differentials facilitates the deposition of a cell within the opening and the creation of a gigaseal between a cell membrane and the surface su ⁇ ounding an opening 222 by blowing clean buffer up through the opening and keeping debris out of the opening until the cell is near the opening.
- positive pressure may be provided into the well through the opening while cells are being loaded. Also evident in Fig. 14 are the relatively short distances between the cell electrodes 215 and 235 and an amplifier 260 that amplifies the input signal to give a strong signal output 265.
- the patch clamp micro chamber shown in Fig. 14 comprises a well for receiving a cell or cells.
- the volume of a well in a patch clamp micro chamber device is minimized, being just enough for handling of the test compound and for cell survival.
- the volume of the well is approximately 300 ⁇ L and the bottom of the well has an
- a patch clamp micro chamber may further comprise a liquid dispensing system that has a dispenser configured to place a cell in solution into a well.
- a well may rapidly be provided with a cell using, for example, automated robotics.
- a first electrode is provided that may be positioned in a well.
- a well electrode may be coupled to one or more dispensers, such that the placement and removal of an electrode is under control of automated robotics.
- Each dispenser may include a seal member to form a seal with the well such that positive pressure may be supplied to each well.
- the liquid dispensing system can dispense liquid to an a ⁇ ay of addressable wells, wherein each of the wells is independently addressable by the automated liquid dispensing system.
- the wells are addressable such that the dispensing system can identify an individual well and place specific cell(s) (or cell type(s)) in a certain well.
- a patch clamp micro chamber comprises a plate having a plurality of wells for receiving cell(s).
- a patch clamp micro chamber having a plurality of wells may further comprise a common chamber disposed adjacent each opening that is used to hold an electrically conductive buffer solution.
- a common electrode is disposed in the chamber, and a plurality of well electrodes are provided that may be positioned within the wells to create a voltage gradient across cell membranes of the cells that are positioned within the openings. Thus, electrophysiological properties of multiple cells or cell membranes may be measured at the same time.
- each individual well has a separate chamber.
- a multi-channel liquid dispensing system has a plurality of dispensers that may be configured to place cells in solution into each of the wells.
- each well may be rapidly provided with a cell using, for example, automated robotics.
- the well electrodes may be coupled to the dispensers, such that placement and removal of an electrode is under control of automated robotics.
- Each dispenser may include a seal member to form a seal with a well such that a positive pressure may be supplied to each well.
- Fig. 15 shows one embodiment of a patch clamp micro chamber with a glass disk according to an embodiment of the invention.
- the device comprises a well 300 for receiving a solution 310 containing cell(s) 320.
- the well further comprises a glass disk 330 that is provided with an opening 340 that separates a well from a chamber 350.
- Electrodes may be configured in a number of ways, for example as shown in Fig. 14.
- Glass disk 330 fits into the micro chamber and is equipped with one or more openings 340.
- the glass disk 330 is removable from the micro chamber and may be used in another micro chamber or a ⁇ ay thereof.
- a vacuum source 360 is coupled to the micro chamber via a tube 370 to produce a vacuum within the chamber. Such a vacuum facilitates the deposition of a cell within the opening 340 and creates a high resistance seal.
- the surface su ⁇ ounding an opening in a laser-drilled glass plate or sheet may be modified to enhance the formation of a high resistance seal between a cell membrane and the surface of an opening in a well.
- Such modifications include, but are not limited to, heating (such as via oven baking) the glass plate, adhering a glue- like substance to the surface of the plate su ⁇ ounding the opening 222, or covalently bonding lipids to the surface of the plate su ⁇ ounding the opening 222.
- the surface of the plate can be modified, as described herein, prior to drilling the openings in the well.
- the glass, glass disk, sheet or plate is heat treated before an experiment, such as by heating (for example via oven baking) the glass to near or at the softening temperature of the glass.
- the softening temperature of a glass is the temperature at which a glass loses enough viscosity that it stops acting like a brittle solid and begins to flow like a liquid.
- borosilicate glass has a softening temperature of 736 °C, so such heat treatment can be at 700 °C for 3 to 10 minutes.
- the heating temperature and time may further vary depending on the hole geometry, dimensions (for example the depth of counter bore, the conical angle of the through hole, and the like), the type of glass and the thickness of the glass.
- a working patch clamp micro chamber comprising a laser-drilled counter bore and
- resistance values can be as high as 10 G ⁇ .
- the glass is ready to be assembled into the micro chamber for a patch clamp experiment.
- the softening temperature of the glass can, for example, be determined using the following method, which can be found at "http://enterprise.as tm.org/PAGES/C338.htm.” which is incorporated by reference herein in its entirety: 1.
- This test method covers the determination of the softening point of a glass by determining the temperature at which a round fiber of the glass, nominally 0.65 mm in diameter and 235 mm long with specified tolerances, elongates under its own weight at a rate of 1 mm min when the upper 100 mm of its length is heated in a specified furnace at the rate of 5 + l°C/min.
- This standard does not purport to address all of the safety problems, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use .
- the surface of the plate su ⁇ ounding an opening is modified by the application of a glue-like substance onto a side wall or surface su ⁇ ounding the opening.
- a glue-like substance onto a side wall or surface su ⁇ ounding the opening.
- This may be accomplished, for example, by dipping the bottom of the multi-well plate in a reservoir containing the glue-like substance and then removing the excess glue by shaking the plate or by applying a small pressure to one side of the plate.
- other known techniques for applying the glue-like substance may be used.
- the cells Once dispensed in the well, the cells will form a tight sealed contact (a gigaseal) with the wall of each well allowing measurements of electrophysiological properties.
- the glue- like substance may comprise a silicone-based glue, a Vaseline/paraffin-based composition, or the like.
- Such a glue-like substance is preferably a chemically inert, soft grease-like substance. This allows the cell to stick to the surface of the through opening and form the gigaseal.
- a seal with a leakage resistance of around 600 mega-ohms to about 1.1 giga- ohms is formed.
- a glue-like substance or lipid surface coating may be placed onto the side wall or surface su ⁇ ounding the opening.
- Fig. 16 shows the covalent attachment of a lipid to a plate surface, such as glass, according to one embodiment of the invention.
- a cell membrane comprises a lipid bilayer. Both layers of the lipid bilayer are made of phosphohpid molecules, each having a polar "head” and non-polar "tail.” In water, phosphohpid molecules align with their polar heads facing the su ⁇ ounding aqueous milieu, and the polar end of the second layer exposed to the aqueous milieu of the cytosol. The non-polar ends of each layer are held in contact and comprise the "interior" of the cell membrane. Bonding a layer of phosphohpid to a surface may be accomplished via covalent or non-covalent bonding.
- a glass surface can be functionalized, e.g., made reactive by attaching an amino-silane moiety to silica and glass surfaces using methods known in the art.
- Lipids having a variety of functional groups suitable for covalent coupling to a modified surface are commercially available, for example, from Avanti Polar Lipids, Inc.
- such functionalized lipids may be used for binding to modified surfaces of the instant invention.
- Methods of covalently attaching functionalized molecules to immobilized molecules on for example surface are known to the skilled artisan.
- suitable complimentary functional groups on a lipid suitable comprise nucleophiles and carbon electrophiles.
- nucleophile and “electrophile” have their usual meanings familiar to synthetic and/or physical organic chemistry.
- Carbon electrophiles comprise one or more alkyl, alkenyl, alkynyl or aromatic (sp 3 , sp 2 , or sp-hybridized) carbon atom substituted with any atom or group having a Pauling electronegativity greater than that of carbon itself.
- prefe ⁇ ed carbon electrophiles examples include but are not limited to carbonyls (especially aldehydes and ketones), oximes, hydrazones, epoxides, aziridines, alkyl-, alkenyl-, and aryl halides, acyls, sulfonates (aryl, alkyl and the like).
- carbon electrophiles include unsaturated carbons
- carbon electrophiles are susceptible to attack by complementary nucleophiles, including carbon nucleophiles, wherein an attacking nucleophile brings an electron pair to the carbon electrophile in order to form a new covalent bond between the nucleophile and the carbon electrophile.
- suitable carbon electrophiles comprise carbonyls, epoxides, aziridines, cyclic sulfates and sulfamidates, and alkyl, vinyl and aryl halides.
- suitable nucleophiles comprise primary and secondary amines, thiols, thiolates, and thioethers, alcohols, alkoxides. These nucleophiles, when used in conjunction with prefe ⁇ ed carbon electrophiles, typically generate heteroatom linkages (C-X-C) between the homing peptides and scaffold, wherein X is a hetereoatom, e.g, oxygen or nitrogen.
- a phosphohpid may comprise a photolabile functional group suitable for coupling to a glass plate or other substrate when activated by light.
- Phospholipids with either amine or activated carboxyl functional groups may be coupled to a surface bearing a complementary function group.
- an amine-bearing lipid will react with a surface bearing NHS ester groups with the concomitant formation of an amide linkage.
- a lipid bearing an NHS ester will react with amine-bearing lipid, also with the concomitant formation of an amide linkage.
- the choice of which permutation of complementary functional groups depends on the experimental conditions faced, e.g. cell type, other components present, or the like.
- One advantageous aspect of the present invention is the modular approach to coupling partners.
- phospholipids bearing a thiol (-SH) functional groups may be coupled to a surface also bearing thiols (-SH) via the formation of disulfide bonds.
- glass surface 600 comprises hydroxyl groups 610, that may be functionalized with aminosilane 620 using known methods. Other methods known in the art can immobilize other reactive groups on a glass surface.
- Other functionalized glass surfaces suitable for coupling to functionalized lipids comprise aldehydes, epoxides, maleimides, nickel chelates, streptavidin, biotin, and thiols.
- aminosilane shown in Fig. 16 has a hydrocarbon linker having five -
- the aminosilane terminates in an amino group 630 that is suitable for covalent coupling to a lipid molecule 640 bearing a complimentary electrophillic functional group 650.
- Fig. 17 illustrates the covalent attachment of lipid molecules 700 on a surface 710 su ⁇ ounding an opening 720 in a patch clamp device according to one embodiment of the invention.
- one end of each lipid molecule is attached to the surface, leaving the other end free to interact with a cell membrane.
- such a covalently bonded layer may dissolve into a membrane.
- a gigaseal is thus established between the surface and the cell.
- Phospholipids may be selectively attached to the surface su ⁇ ounding the hole.
- holes may be laser drilled in a plate or substrate before covalently attaching a lipid. A lipid may then be to selectively linked using a photo-labile functional group. Other areas of the plate or disk may be photo-masked.
- Liquid chemical treatments may also be used to increase the affinity of a cell membrane for a polymer surface.
- One example is exposure to caustic soda solution.
- the alkaline solution hydrolyses ester groups at the polymer surface, increasing the wettability and also the surface affinity for charged bipolar lipid membranes.
- Figs. 18 A and B illustrates gigaseal formation according to an embodiment of the present invention, for example using a pressure control system.
- a glass plate 800 provided with an opening 810.
- the opening geometry may be of any type disclosed herein.
- a positive pressure 820 is applied to the bottom chamber during the filling the upper chamber with a solution comprising cell(s) 840.
- such conditions have the effect of creating an expanding region or "bubble" of clean intra cellular solution radiating outward 830 from the hole into the well containing the cell(s). Given micro fluidic properties, an expanding bubble of clean fluid is formed without turbulence.
- the "bubble” can cany the debris and clumps farther away from the hole than the "good” cells as the collection of cells fall to the bottom.
- suction or negative pressure 850 is applied to collapse the "bubble” of clean fluid.
- a "good " cell 860 is sucked into the hole before the debris and the clumps.
- the gigaseal is formed reliably and a "good” cell remains within bubble 860, while the dead or diseased cells and debris remain outside of bubble 850.
- the following stepwise protocol is an example of a protocol that may be used to reliably form a gigaseal using any of the patch clamp devices disclosed herein.
- the patch clamp chamber is loaded and the electrodes are properly assembled.
- about lOOuL of cells are dispensed at 5 millions/mL into the top well, which was previously loaded with about lOuL of Ringer solution (the solution inside of the pipette).
- a pressure is applied to the bottom chamber. In one embodiment, pressure is applied using a lOmL syringe. The syringe is compressed to 5mL from lOmL for a pressure of about 14 psi. Then the plunger is released.
- the plunger generally returns to 9.8 mL slowly which is about 0.3 psi.
- One minute is a good example of the amount of time to wait because previous experiments have shown that cells generally settle in 1 minute.
- the above procedure and parameters may be optimized for particular cells and other experimental variables.
- a high success rate of gigaseal formation can be achieved with this procedure; an overall success rate of 80% may be achieved.
- the devices and techniques of the invention facilitate the formation gigaseals between a cell and an opening in the wells of a multi-well plate.
- the invention further provides methods for automating the screening of ion channel assays and enables the parallel processing of many compounds and many cells at once.
- the invention may utilize native cell lines for example, CHO, Jurkat, HEK and hERG.
- the invention provides the ability to screen the same compound against multiple targets in the same experiment which increases throughput.
- the invention may be used to determine whether drugs are good modulators of ion channels.
- the invention allows maximum flexibility and control over the components of each well.
- the device allows the contents of each well, cell type, drug candidate, buffer and ion concentration etc., to be different depending on the experiment at hand.
- the present invention provides the ability to use the ion channels as "biosensors.”
- drugs may affect other molecular targets within a cell and may influence ion channel activity. Effects observed by measurements of electrophysiological properties using devices and methods disclosed herein may be co ⁇ elated with mechanism of drug action and may be quantified in terms of drug concentrations, e.g., the effectiveness of a particular drug. Such precise measurements are useful when comparing or distinguishing drug candidates to one another.
- drug-induced modulation of protein kinases and phosphatases within cells which in turn changes the kinetic behavior of certain ion channels, may be detected and recorded with high precision electrophysiological assays, using the device and methods disclosed herein. Further, some cell lines may be used to evaluate the effect of the same drug on specific kinases, phosphatases, the phosphorylation of ion channels, and an effect of a drug on the channel itself.
- the device may be used to measure precise pH changes.
- Proton-gated ion channels are selective to protons only, H + or alternatively, hydronium ions H 3 + O.
- Such proton selective ion channels are natural pH meters because when two solutions with different ion concentrations are separated by a selective membrane, such as a ion channel, it is possible to observe a concentration as a potential difference. Moreover, when such differences exist, ions will migrate to alleviate the imbalance. This flow may be observed as an ionic cu ⁇ ent.
- Certain commercial pH meters lack precision because the semi-permeable glass membranes which they employ suffer interference by other ions, for example, by sodium Na + ions. Because proton ion channels are selective for protons, an ion channel-based pH meter represents an improvement over the existing state of the art. Thus, the present invention may serve as an alternative to a micro physiometer.
- the device and methods disclosed herein may be used to construct a "proton biosensor" for drug discovery.
- Introduction of certain drugs into a cell may lead to a change in intracellular pH.
- the device may act as a pH meter itself, for example, when the drug is unable to pass through the cell membrane. In this case, measured changes in pH co ⁇ espond to solution pH within a well.
- the electrophysiological information output from a single experiment of the invention can comprise multiple parameters that are recorded essentially simultaneously.
- the techniques of the invention also provide the ability to dialyze the cell cytoplasm, thus allowing one to manipulate the intracellular solution composition, introducing or removing certain ions from the intracellular solution.
- an experiment may dialyze a cell cytoplasm to evaluate one type of channel while excluding other channel types. This permits the optimization of one channel while excluding others.
- the electrophysiological methods have high sensitivity, allowing one to record the activity of a single channel molecule.
- the techniques of the invention also have high temporal resolution (in sub- millisecond range) which is useful for some ion channel targets, such as fast deactivating Na channels.
- Ionic cu ⁇ ents flowing through ion channels are on the order of several pico amperes (pA) and thus are challenging to measure precisely.
- relatively short distances, e.g., a few millimeters, between the cell electrodes and the amplifier minimize electrical noise pickup.
- a chip based amplifier may cleanly convert a pA signal to a mV signal.
- Common multichannel data acquisition boards can acquire this signal without difficulty.
- electronics are provided to measure voltage and/or cu ⁇ ent values for each of the wells.
- a controller may also be provided to control operation of the liquid dispensing system and the electronics.
- a voltage source is coupled to the common electrode to create the voltage gradient.
- the invention provides a method for evaluating electrical cu ⁇ ents flowing through ion channels of a plurality of cells.
- This method utilizes a plate having a plurality of wells that each have an end. At least some of the wells have an opening formed in the end, and a chamber is disposed below the plate and is filled with an electrolyte solution. A common electrode is also disposed in the chamber. With such a configuration, cells are dispensed in a solution into the wells. A pressure differential is applied between the wells and the chamber to collect cells into the openings and to create a high resistance seal between the cells and the ends of the wells. A potential difference is produced between the common electrode and well electrodes that are positioned within each well.
- Measurements of electrophysiological properties are taken from the cells or cell membranes that are positioned within the openings.
- a plurality of cells may be evaluated in parallel to create a high throughput screening system.
- cells may be deposited into the chamber and then drawn into the openings so that only a small portion of the cells are within the openings. The portions of the cells extending into the chamber may then be penetrated and measurements taken as previously described.
- the invention further provides a method for evaluating electrical cu ⁇ ents flowing through ion channels of the cell.
- the method utilizes at least one well having an end and a sidewall in the end that forms an opening through the end of the well.
- a glue-like substance is placed on the sidewall of the opening and one or more cells are deposited into the opening.
- the glue is used to create a high resistance seal between the cell and the sidewall opening formation.
- a potential difference is then created across the cell membrane and voltage and/or cu ⁇ ent measurements are taken and recorded.
- such a method produces a high resistance seal that is sufficient to make precise electrophysiological measurements.
- such a technique permits the use of simple and inexpensive multi-well plates that are constructed of plastic or glass, rather than silicon and nitride or glass multi-usage plates.
- One example of a procedure for performing a screening experiment is by providing a cell line with expressed target ion channels. Each well is configured to receive a few of these cells, although only one cell per well is necessarily measured.
- the plate is placed onto the chamber having an intracellular solution.
- the common electrode positioned in the chamber may be constructed of a metal plate that may be shifted to allow the solution to flow downward from each of the wells. Further, it will be appreciated that more than one common electrode may be used. For example, two or three common electrodes may be used.
- a slight pressure may be applied to each well, or a vacuum may be supplied to permit the cells to plug the through openings, thereby blocking them.
- Such procedure may take about 1 to 3 minutes to permit the cells to form high resistance seals with the holes in the end of each well.
- the metal plate may then be shifted back to perforate the lower portion of the cells that are put through each well by the applied pressure.
- pressure pulses or a perforation solution may be used to perforate the cells.
- the cells may be penetrated by electroporation. After perforating the lower portion of the cells, the system is ready to record electrophysiological properties in a high throughput manner.
- a voltage of about -70 mV voltage difference is produced between the intracellular electrode (the common electrode that is formed from a metal plate) and each of the needles that are disposed in the well.
- the voltage is negative in this example because ground is defined to be at the exterior of the cell.
- each well Before taking measurements, each well may be tested to determine whether the seal has been formed. If not, the well is labeled as a well having a "bad" seal (without a gigaseal) and may be discarded from subsequent considerations. The plate may be tested multiple times during the experiment to reconfirm the stability of seal formation. Applying small hyperpolarized pulses to the cell membranes may test each well. By excluding the wells without gigaseals from further consideration, ligands are effectively saved by applying them only to the "successful" wells.
- Individual cell voltage and cu ⁇ ent measurements may then be taken and recorded using normal patch clamp electronics.
- the recorded data is stored and evaluated to determine the effectiveness of the compounds being tested. Further, the cells may be evaluated in a high throughput manner.
- Figs. 19A and 19B shows two methods of employing SQUID for the detection of ionic cu ⁇ ents according to an embodiment of the present invention.
- a SQUID is a magnetic field sensor with high sensitivity.
- SQUID stands for "Superconducting QUantum Interference
- SQUID Small changes in magnetic fields can be measured very sensitively with high precision. Variants of SQUID are also suitable for the measurement of magnetic field gradients, voltages, cu ⁇ ent, and magnetic susceptibilities.
- the output voltage of a SQUID is sinusoidal as a function of applied magnetic flux. Consequently, its behavior is nonlinear and periodic. One period co ⁇ esponds with the
- a very sensitive cu ⁇ ent amplification can be obtained.
- Yet another way to increase SQUID sensitivity is to use a number of SQUIDS in series. When n such SQUIDS operate in phase, the output voltage increases in proportion to n, while the SQUID noise increases more slowly, in proportion to the square root of n.
- One method of employing SQUID(s) according to an embodiment of the invention is to pass the cu ⁇ ent generated by an ion channel through a wire and thereby generate a magnetic field for the SQUID to detect as shown in Fig. 19B.
- Such a detector has the advantage of decoupling a cu ⁇ ent measurement from the voltage stimulation.
- a pneumatic electrical switch is used to switch the detector to different cells automatically without introducing excessive electrical noise.
- multiplexing such as by using a recording device to sequentially record multiple wells, can be accomplished.
- Multiplexing is a term used to describe use of an input that can be switched to multiple sources to sample the measurements in sequence.
- Each recording device allows a reading from one well.
- multiple recording devices can allow for parallel multiplexing.
- an a ⁇ ay of pneumatic cylinders can be used to mechanically plug the cables into the proper sockets for reduced-noise connection. The compressed air is switched far away from the detection system. The location of the switch can be very close to the cell to minimize the cable length, also to minimize cable capacitance and inductance.
- a SQUID sensor can sense the weak magnetic field that the ion channel cu ⁇ ent generates when it is placed near the cell.
- an hourglass shaped capillary holds the cells or a SQUID sensor encircles an opening on a flat substrate or plate as shown in Fig. 19 A.
- a SQUID device 400 is configured to detect changes in magnetic flux via loop 410 that encircles opening 420 and thus the path of ionic cu ⁇ ent. According to this embodiment, a SQUID device acts independently of the circuit comprising the two electrodes 430 and 440, and measuring device 450.
- Fig. 19B shows a SQUID device 500 configured to detect changes in magnetic flux via loop 510, that encircles wire 520.
- a SQUID device detects a signal that may be physically displaced from the ion channel and or cell chamber.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02707739A EP1358474A2 (fr) | 2001-02-09 | 2002-02-08 | Dispositifs et procedes destines a des tests patch clamp a haut debit |
JP2002564562A JP2004528539A (ja) | 2001-02-09 | 2002-02-08 | 高スループットパッチクランプアッセイのための装置および方法 |
AU2002242128A AU2002242128A1 (en) | 2001-02-09 | 2002-02-08 | Devices and methods for high throughput patch clamp assays |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/779,955 US20020108869A1 (en) | 2001-02-09 | 2001-02-09 | Device and technique for multiple channel patch clamp recordings |
US09/779,955 | 2001-02-09 | ||
US10/029,425 | 2001-12-21 | ||
US10/029,425 US20020164777A1 (en) | 2001-02-09 | 2001-12-21 | Devices and methods for high throughput patch clamp assays |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002065092A2 true WO2002065092A2 (fr) | 2002-08-22 |
WO2002065092A9 WO2002065092A9 (fr) | 2002-11-28 |
WO2002065092A3 WO2002065092A3 (fr) | 2003-02-20 |
Family
ID=26704933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/003700 WO2002065092A2 (fr) | 2001-02-09 | 2002-02-08 | Dispositifs et procedes destines a des tests patch clamp a haut debit |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1358474A2 (fr) |
JP (1) | JP2004528539A (fr) |
WO (1) | WO2002065092A2 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1546348A1 (fr) * | 2002-08-21 | 2005-06-29 | Cellectricon AB | Systeme et procede destines a obtenir et a maintenir des joints haute resistance dans des enregistrements de patch-clamp |
EP1801586A1 (fr) * | 2002-08-21 | 2007-06-27 | Cellectricon AB | Procédé et système pour obtenir des joints conservant une grande résistance dans des enregistrements patch-clamp |
US7723029B2 (en) | 2002-01-24 | 2010-05-25 | Aviva Biosciences Corporation | Biochips including ion transport detecting structures and methods of use |
US7968305B2 (en) | 2001-03-24 | 2011-06-28 | Aviva Biosciences Corporation | Biochips including ion transport detecting structures and methods of use |
US8030059B2 (en) | 2003-11-21 | 2011-10-04 | Panasonic Corporation | Apparatus for measuring extracellular potential |
US8202439B2 (en) | 2002-06-05 | 2012-06-19 | Panasonic Corporation | Diaphragm and device for measuring cellular potential using the same, manufacturing method of the diaphragm |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060029955A1 (en) | 2001-03-24 | 2006-02-09 | Antonio Guia | High-density ion transport measurement biochip devices and methods |
JP4691407B2 (ja) * | 2005-06-29 | 2011-06-01 | パナソニック株式会社 | 細胞電位測定用容器 |
JP4834335B2 (ja) * | 2005-06-29 | 2011-12-14 | パナソニック株式会社 | 細胞電位測定用容器 |
JP4661539B2 (ja) * | 2005-11-11 | 2011-03-30 | パナソニック株式会社 | 細胞電気生理センサおよびその製造方法 |
US8329009B2 (en) * | 2010-04-09 | 2012-12-11 | Molecular Devices, Llc | High throughput screening of ion channels |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4324255A (en) * | 1980-03-07 | 1982-04-13 | Barach John P | Method and apparatus for measuring magnetic fields and electrical currents in biological and other systems |
US5506141A (en) * | 1982-05-10 | 1996-04-09 | Bar-Ilan University | Apertured cell carrier |
US6071702A (en) * | 1998-09-04 | 2000-06-06 | Hitachi Software Engineering Co., Ltd. | Probe-bearing element and method for producing the same |
US20020064841A1 (en) * | 2000-02-11 | 2002-05-30 | Klemic Kathryn G. | Planar patch clamp electrodes |
-
2002
- 2002-02-08 JP JP2002564562A patent/JP2004528539A/ja active Pending
- 2002-02-08 EP EP02707739A patent/EP1358474A2/fr not_active Withdrawn
- 2002-02-08 WO PCT/US2002/003700 patent/WO2002065092A2/fr not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4324255A (en) * | 1980-03-07 | 1982-04-13 | Barach John P | Method and apparatus for measuring magnetic fields and electrical currents in biological and other systems |
US5506141A (en) * | 1982-05-10 | 1996-04-09 | Bar-Ilan University | Apertured cell carrier |
US6071702A (en) * | 1998-09-04 | 2000-06-06 | Hitachi Software Engineering Co., Ltd. | Probe-bearing element and method for producing the same |
US20020064841A1 (en) * | 2000-02-11 | 2002-05-30 | Klemic Kathryn G. | Planar patch clamp electrodes |
Non-Patent Citations (2)
Title |
---|
ALMERS ET AL.: 'Slow calcium and potassium currents across frog muscle membrane: measurements with a vaseline-gap technique' J. PHYSIOL. vol. 312, 1981, pages 159 - 176, XP002959619 * |
COSTA ET AL.: 'Improved technique for studying ion channels expressed in xenopus oocytes, including fast superfusion' BIOPHYSICAL JOURNAL vol. 67, July 1994, pages 395 - 401, XP002959618 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7968305B2 (en) | 2001-03-24 | 2011-06-28 | Aviva Biosciences Corporation | Biochips including ion transport detecting structures and methods of use |
US7723029B2 (en) | 2002-01-24 | 2010-05-25 | Aviva Biosciences Corporation | Biochips including ion transport detecting structures and methods of use |
US8202439B2 (en) | 2002-06-05 | 2012-06-19 | Panasonic Corporation | Diaphragm and device for measuring cellular potential using the same, manufacturing method of the diaphragm |
EP1546348A1 (fr) * | 2002-08-21 | 2005-06-29 | Cellectricon AB | Systeme et procede destines a obtenir et a maintenir des joints haute resistance dans des enregistrements de patch-clamp |
EP1546348A4 (fr) * | 2002-08-21 | 2005-12-14 | Cellectricon Ab | Systeme et procede destines a obtenir et a maintenir des joints haute resistance dans des enregistrements de patch-clamp |
EP1801586A1 (fr) * | 2002-08-21 | 2007-06-27 | Cellectricon AB | Procédé et système pour obtenir des joints conservant une grande résistance dans des enregistrements patch-clamp |
US7390650B2 (en) | 2002-08-21 | 2008-06-24 | Cellectricon Ab | System and method for obtaining and maintaining high-resistance seals in patch clamp recordings |
US8030059B2 (en) | 2003-11-21 | 2011-10-04 | Panasonic Corporation | Apparatus for measuring extracellular potential |
US8247218B2 (en) | 2003-11-21 | 2012-08-21 | Panasonic Corporation | Extracellular potential sensing element, device for measuring extracellular potential, apparatus for measuring extracellular potential and method of measuring extracellular potential by using the same |
Also Published As
Publication number | Publication date |
---|---|
WO2002065092A3 (fr) | 2003-02-20 |
JP2004528539A (ja) | 2004-09-16 |
WO2002065092A9 (fr) | 2002-11-28 |
EP1358474A2 (fr) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020164777A1 (en) | Devices and methods for high throughput patch clamp assays | |
US9146221B2 (en) | High-density ion transport measurement biochip devices and methods | |
US11898984B2 (en) | Nanopore arrays for sequencing nucleic acids | |
US7494622B2 (en) | Device for measuring the electrical activity of biological elements and its applications | |
Baaken et al. | Planar microelectrode-cavity array for high-resolution and parallel electrical recording of membrane ionic currents | |
US7270730B2 (en) | High-throughput electrophysiological measurement system | |
US20050058990A1 (en) | Biochip devices for ion transport measurement, methods of manufacture, and methods of use | |
CA2468424A1 (fr) | Procede d'administration parallele combinee d'agents et d'electroporation pour structures cellulaires et utilisation associee | |
JP5948355B2 (ja) | 電気生理学的分析のためのハンドヘルド装置 | |
WO2002065092A2 (fr) | Dispositifs et procedes destines a des tests patch clamp a haut debit | |
Arrigan et al. | 3 BioanalyticalApplications of Electrochemistry | |
US20050009171A1 (en) | Device and method for analyzing ion channels in membranes | |
WO2005029056A1 (fr) | Dispositif et procede a double membrane de formation de lipides artificiels, et methode d'utilisation | |
JP2005536751A (ja) | パッチクランプ記録において高抵抗固着を獲得して維持するシステム及び方法 | |
JP2005511039A (ja) | 自動パッチクランプ記録用液体界面形態 | |
WO2003021230A2 (fr) | Systeme de mesure electrophysiologique de grande capacite | |
JP2008518594A (ja) | 細胞特性を測定するための装置および方法 | |
EP1910396A2 (fr) | Dispositifs a biopuces de mesure de transport ionique de haute densite et procedes | |
US20040020773A1 (en) | Apparatus and method for determining and/or monitoring electrophysiological properties of ion channels | |
WO2005007866A2 (fr) | Dispositifs de biopuces pour une mesure de transport ionique, methodes de fabrication, et methodes d'utilisation associees | |
Weber | Manufacturing of Gold Nanoelectrode Ensembles for Intracellular Recording on Living Cells | |
JP2021186701A (ja) | 脂質二重膜の形成方法並びにそのための隔壁及び器具 | |
Jadhav | Design and characterization of nanostructured biomimetic interfaces containing bilayer lipid membranes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/18-18/18, DRAWINGS, REPLACED BY NEW PAGES 1/16-16/16; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002564562 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002707739 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002707739 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002707739 Country of ref document: EP |